QA: Oramed Pharmaceuticals INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001176309_2020_Oramed_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0001176309, Oramed Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 33,324,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 24,000
3 remainder_Assets 1,315,000
4 LiabilitiesCurrent 5,308,000
5 LiabilitiesNoncurrent 9,962,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 69,391
8 SellingGeneralAndAdministrativeExpense 3,687,738
9 ResearchAndDevelopmentExpense 14,495,744
10 remainder_Expenses 557,557
11 remainder_Revenues 4,101,760
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 32,669
  yvar yval
0 Assets 34,663,000
1 Liabilities 15,270,000
2 Expenses 18,810,430
3 Revenues 4,101,760
4 StockholdersEquity 19,393,000
5 NetIncome -14,708,670
6 ComprehensiveNetIncome -14,692,336
7 BaseVar 36,438,930
8 EconomicCapitalRatiobeforeLimitedLiability 1.10
9 EconomicCapitalRatio 2.38

Edgar->Model Mapping

Feature Distribution

Change over Time